Chondroblastoma is a rare and benign bone tumor that primarily affects the epiphyses (ends) of long bones, most commonly in the knee or proximal humerus. It predominantly occurs in individuals between the ages of 10 and 25. Chondroblastoma is characterized by the presence of chondroblasts, which are immature cartilage-forming cells. Symptoms may include localized pain, swelling, and reduced joint mobility. Radiographically, chondroblastoma typically appear as well-defined lesions with a characteristic soap-bubble or eccentric appearance on X-rays. Diagnosis is confirmed through imaging studies and often requires a biopsy for histological examination. Treatment options for chondroblastomas include curettage (surgical removal of the tumor) with or without bone grafting. While chondroblastomas are generally considered benign, they can be locally aggressive, and recurrence is possible. Regular follow-up and monitoring are crucial to detect any recurrence or complications. Comprehensive understanding of chondroblastomas is essential in orthopaedics, guiding appropriate diagnostic and therapeutic interventions for individuals affected by this relatively rare bone tumor.